文献速递骨软组织肉瘤与黑色素瘤

皮肤肿瘤学中免疫检查点抑制剂的最新综述:超越黑色素瘤

An updated review of immune checkpoint inhibitors in cutaneous oncology: Beyond melanoma.
PubMed 文献 · Eur J Cancer · 2024-11-16

本综述更新了过去三年免疫检查点抑制剂在黑色素瘤以外皮肤恶性肿瘤中的临床试验、真实世界分析和转化研究证据,重点讨论了临床试验中代表性不足的人群、转移性疾病以外的新治疗场景、新型联合方案以及可靠预测性生物标志物的迫切需求。

要点

  • 免疫检查点抑制剂在黑色素瘤以外的多种非黑色素瘤皮肤恶性肿瘤中显示出应用潜力。
  • 需进一步评估的人群包括临床试验中代表性不足或未被纳入的人群。
  • 迫切需要可靠的预测性生物标志物来识别治疗反应的预测因素。

核心结论

  • 新兴证据表明免疫检查点抑制剂在皮肤肿瘤学中的应用已扩展至多种非黑色素瘤恶性肿瘤。

研究设计与样本

  • 本综述汇总了过去三年关于黑色素瘤以外皮肤恶性肿瘤的临床试验、真实世界分析和转化研究证据。

主要发现

  • 免疫检查点抑制剂在皮肤肿瘤学中的应用已扩展至多种非黑色素瘤恶性肿瘤。

临床怎么用

  • 肿瘤科医生、皮肤科医生和皮肤外科医生之间的合作对于推进晚期皮肤恶性肿瘤患者的理解和治疗至关重要。

局限性

  • 需进一步评估的领域包括临床试验中代表性不足或未被纳入的人群、转移性疾病以外的新治疗场景、新型联合方案以及可靠预测性生物标志物的迫切需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Over the last decade, immune checkpoint inhibitors (ICIs) have been established as an integral component of the contemporary anticancer armamentarium. In dermatology, ICIs are most established as treatment of advanced melanoma. However, emerging evidence has demonstrated that their utility in cutaneous oncology extends to a variety of other non-melanoma malignancies. This review provides an update of the evidence from clinical trials, real world analyses, and translational research over the last three years in cutaneous malignancies beyond melanoma. Special focus is presented on areas warranting further evaluation - including populations underrepresented in or excluded from clinical trials; new and emerging treatment scenarios beyond patients with metastatic disease; novel combination approaches; and the urgent need for reliable predictive biomarkers to identify predictors of response. Collaboration between oncologists, dermatologists and dermatological surgeons is essential to progress our understanding and treatment of patients with advanced cutaneous malignancies.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Pham JP, Staeger R, Joshua AM, et al. An updated review of immune checkpoint inhibitors in cutaneous oncology: Beyond melanoma. Eur J Cancer. 2024. PMID: 39580882. doi:10.1016/j.ejca.2024.115121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。